Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8,903 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Is switching antidepressants following early nonresponse more beneficial in acute-phase treatment of depression?: a randomized open-label trial.
Nakajima S, Uchida H, Suzuki T, Watanabe K, Hirano J, Yagihashi T, Takeuchi H, Abe T, Kashima H, Mimura M. Nakajima S, et al. Among authors: abe t. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Dec 1;35(8):1983-9. doi: 10.1016/j.pnpbp.2011.08.008. Epub 2011 Aug 24. Prog Neuropsychopharmacol Biol Psychiatry. 2011. PMID: 21889560 Clinical Trial.
Effects of risperidone and olanzapine dose reduction on cognitive function in stable patients with schizophrenia: an open-label, randomized, controlled, pilot study.
Takeuchi H, Suzuki T, Remington G, Bies RR, Abe T, Graff-Guerrero A, Watanabe K, Mimura M, Uchida H. Takeuchi H, et al. Among authors: abe t. Schizophr Bull. 2013 Sep;39(5):993-8. doi: 10.1093/schbul/sbt090. Epub 2013 Jul 1. Schizophr Bull. 2013. PMID: 23821768 Free PMC article. Clinical Trial.
Baseline difference between patients' and clinicians' rated illness severity scores and subsequent outcomes in major depressive disorder: analysis of the sequenced treatment alternatives to relieve depression data.
Tada M, Uchida H, Suzuki T, Abe T, Pollock BG, Mimura M. Tada M, et al. Among authors: abe t. J Clin Psychopharmacol. 2014 Jun;34(3):297-302. doi: 10.1097/JCP.0000000000000112. J Clin Psychopharmacol. 2014. PMID: 24743720 Free PMC article. Clinical Trial. No abstract available.
Acceptability of escitalopram versus duloxetine in outpatients with depression who did not respond to initial second-generation antidepressants: Study protocol for a randomized, parallel-group, non-inferiority trial.
Yokoi Y, Nakagawa A, Yoshimura N, Furukawa TA, Mimura M, Iwanami A, Abe T, Nakagome K. Yokoi Y, et al. Among authors: abe t. Neuropsychopharmacol Rep. 2019 Dec;39(4):262-272. doi: 10.1002/npr2.12078. Epub 2019 Sep 18. Neuropsychopharmacol Rep. 2019. PMID: 31531962 Free PMC article.
Neural and clinical changes of cognitive behavioural therapy versus talking control in patients with major depression: a study protocol for a randomised clinical trial.
Katayama N, Nakagawa A, Kurata C, Sasaki Y, Mitsuda D, Nakao S, Mizuno S, Ozawa M, Nakagawa Y, Ishikawa N, Umeda S, Terasawa Y, Tabuchi H, Kikuchi T, Abe T, Mimura M. Katayama N, et al. Among authors: abe t. BMJ Open. 2020 Feb 25;10(2):e029735. doi: 10.1136/bmjopen-2019-029735. BMJ Open. 2020. PMID: 32102803 Free PMC article.
8,903 results